1. Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver disease. Issue 3 (March 2018) Authors: Moser, Stephan; Kozbial, Karin; Laferl, Hermann; Schütz, Angelika; Reiberger, Thomas; Schwabl, Philipp; Gutic, Enisa; Schwanke, Cornelia; Schubert, Raphael; Luhn, Julian; Lang, Tobias; Schleicher, Michael; Steindl-Munda, Petra; Haltmayer, Hans; Ferenci, Peter; Gschwantler, Michael Journal: European journal of gastroenterology & hepatology Issue: Volume 30:Issue 3(2018:Mar.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗